Silence Therapeutics PLC
NASDAQ:SLN
Silence Therapeutics PLC
NASDAQ:SLN
Price:
23.35 USD
1.52%
Updated:
May 21, 2024
Balance Sheet
Balance Sheet Decomposition
Silence Therapeutics PLC
Silence Therapeutics PLC
| Current Assets | 90.7m |
| Cash & Short-Term Investments | 50.3m |
| Receivables | 38.3m |
| Other Current Assets | 2.1m |
| Non-Current Assets | 9.4m |
| Long-Term Investments | 293k |
| PP&E | 832k |
| Intangibles | 28k |
| Other Non-Current Assets | 8.2m |
| Current Liabilities | 9.2m |
| Other Current Liabilities | 9.2m |
| Non-Current Liabilities | 63.2m |
| Other Non-Current Liabilities | 63.2m |
Balance Sheet
Silence Therapeutics PLC
Silence Therapeutics PLC
Currency: GBP
| Dec-2015 | Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | ||
|---|---|---|---|---|---|---|
| Assets | ||||||
| Cash & Cash Equivalents |
52
|
39
|
43
|
21
|
14
|
|
| Cash Equivalents |
52
|
39
|
43
|
21
|
14
|
|
| Short-Term Investments |
0
|
0
|
0
|
5
|
20
|
|
| Total Receivables |
1
|
3
|
2
|
2
|
4
|
|
| Accounts Receivables |
0
|
1
|
0
|
0
|
0
|
|
| Other Receivables |
1
|
2
|
2
|
2
|
0
|
|
| Other Current Assets |
0
|
0
|
1
|
1
|
0
|
|
| Total Current Assets |
54
|
42
|
46
|
29
|
37
|
|
| PP&E Net |
1
|
1
|
1
|
1
|
1
|
|
| PP&E Gross |
1
|
1
|
1
|
1
|
1
|
|
| Accumulated Depreciation |
3
|
3
|
4
|
3
|
3
|
|
| Intangible Assets |
0
|
0
|
0
|
0
|
0
|
|
| Note Receivable |
0
|
0
|
0
|
0
|
0
|
|
| Long-Term Investments |
0
|
4
|
0
|
0
|
0
|
|
| Other Assets |
7
|
8
|
8
|
8
|
8
|
|
| Total Assets |
62
N/A
|
56
-9%
|
55
-1%
|
39
-29%
|
46
+18%
|
|
| Liabilities | ||||||
| Accounts Payable |
0
|
1
|
0
|
1
|
2
|
|
| Accrued Liabilities |
1
|
1
|
2
|
3
|
5
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
|
| Other Current Liabilities |
0
|
0
|
0
|
0
|
2
|
|
| Total Current Liabilities |
1
|
2
|
3
|
4
|
10
|
|
| Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
|
| Other Liabilities |
0
|
0
|
0
|
0
|
16
|
|
| Total Liabilities |
1
N/A
|
2
+44%
|
3
+65%
|
4
+44%
|
25
+557%
|
|
| Equity | ||||||
| Common Stock |
3
|
3
|
4
|
4
|
4
|
|
| Retained Earnings |
77
|
85
|
86
|
104
|
123
|
|
| Additional Paid In Capital |
133
|
133
|
133
|
133
|
138
|
|
| Other Equity |
1
|
3
|
2
|
2
|
2
|
|
| Total Equity |
60
N/A
|
54
-10%
|
52
-3%
|
35
-33%
|
21
-40%
|
|
| Total Liabilities & Equity |
62
N/A
|
56
-9%
|
55
-1%
|
39
-29%
|
46
+18%
|
|
| Shares Outstanding | ||||||
| Common Shares Outstanding |
70
|
70
|
70
|
71
|
78
|
|
Switch to:
Switch to:
See Also
Discover More
You don't have any saved screeners yet
